Table 4. Toxicity profile of the oxazole compounds (1-6).
| Toxicity | |||||||
| Compound | aLD50 (mg/kg) | Class | HEPATOTOXICITY | CARCINOGENICITY | IMMUNOTOXICITY | MUTAGENICITY | CYTOTOXICITY |
| 1 | 1000mg/kg | 4 | Inactive | Inactive | Inactive | Inactive | Inactive |
| 2 | 1600mg/kg | 4 | Inactive | Inactive | Inactive | Inactive | Inactive |
| 3 | 1500mg/kg | 4 | Inactive | Inactive | Inactive | Inactive | Inactive |
| 4 | 1420mg/kg | 4 | Inactive | Active | Inactive | Active | Inactive |
| 5 | 1500mg/kg | 4 | Inactive | Inactive | Inactive | Inactive | Inactive |
| 6 | 1000mg/kg | 4 | Inactive | Active | Inactive | Active | Inactive |
| Azithromycin | 2000mg/kg | 4 | Inactive | Inactive | Active | Inactive | Inactive |
| Sulfanilamide | 3000mg/kg | 5 | Inactive | Active | Inactive | Inactive | Inactive |
| Sulfamethoxazole | 2300mg/kg | 5 | Active | Active | Inactive | Inactive | Inactive |
| a LD50: lethal dose parameter |